Sale!

TRDN Gene Ventricular Tachycardia Catecholaminergic Polymorphic Type 5 Genetic Test

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The TRDN gene ventricular tachycardia catecholaminergic polymorphic type 5 genetic test is a specialized diagnostic tool designed to identify mutations in the TRDN gene, which are associated with catecholaminergic polymorphic ventricular tachycardia (CPVT) type 5. CPVT is a rare, potentially life-threatening genetic disorder characterized by an abnormal heart rhythm (arrhythmia) that can lead to fainting, seizures, or sudden death, especially during physical activity or emotional stress. The condition is caused by mutations in genes that are important for the heart’s electrical activity, including the TRDN gene.

This test is available at DNA Labs UAE, a leading provider of genetic testing services in the United Arab Emirates. The cost of the test is 4400 AED. By analyzing a patient’s DNA, the test can confirm a diagnosis of CPVT type 5, inform treatment decisions, and help assess the risk to family members. Early diagnosis and management are crucial for individuals with CPVT to prevent serious complications. DNA Labs UAE employs advanced genetic testing technologies to ensure accurate and reliable results, providing essential information for patients and their healthcare providers.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

TRDN Gene Ventricular Tachycardia Catecholaminergic Polymorphic Type 5 Genetic Test

Components: TRDN Gene Ventricular tachycardia catecholaminergic polymorphic type 5 Genetic Test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Cardiovascular Pneumology Disorders

Doctor: Cardiologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for TRDN Gene Ventricular tachycardia, catecholaminergic polymorphic type 5 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TRDN Gene Ventricular tachycardia, catecholaminergic polymorphic type 5 NGS Genetic DNA Test gene TRDN

Test Details: The TRDN gene is associated with a genetic condition called catecholaminergic polymorphic ventricular tachycardia type 5 (CPVT5). This condition is characterized by abnormal heart rhythms, specifically ventricular tachycardia, which can be life-threatening if not managed properly. NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or the entire genome. In the case of CPVT5, NGS genetic testing can be used to identify mutations or variations in the TRDN gene that may be responsible for the condition. By analyzing the TRDN gene using NGS, healthcare professionals can determine if an individual has any genetic changes that are associated with CPVT5. This information can help with diagnosis, prognosis, and treatment planning for individuals with this condition.

Test Name TRDN Gene Ventricular tachycardia catecholaminergic polymorphic type 5 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Cardiovascular Pneumology Disorders
Doctor Cardiologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for TRDN Gene Ventricular tachycardia, catecholaminergic polymorphic type 5 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with TRDN Gene Ventricular tachycardia, catecholaminergic polymorphic type 5 NGS Genetic DNA Test gene TRDN
Test Details

The TRDN gene is associated with a genetic condition called catecholaminergic polymorphic ventricular tachycardia type 5 (CPVT5). This condition is characterized by abnormal heart rhythms, specifically ventricular tachycardia, which can be life-threatening if not managed properly.

NGS (Next-Generation Sequencing) genetic testing is a type of genetic testing that allows for the simultaneous analysis of multiple genes or the entire genome. In the case of CPVT5, NGS genetic testing can be used to identify mutations or variations in the TRDN gene that may be responsible for the condition.

By analyzing the TRDN gene using NGS, healthcare professionals can determine if an individual has any genetic changes that are associated with CPVT5. This information can help with diagnosis, prognosis, and treatment planning for individuals with this condition.